South Texas Accelerated Research Therapeutics (START) Midwest — Grand Rapids, Michigan

South Texas Accelerated Research Therapeutics (START) Midwest is a clinical research site located in Grand Rapids, Michigan, United States 49546.

Crixeo Clinical Trials Trust Score: 21/100 (FAILING). This profile has not yet been claimed by the site owner.

South Texas Accelerated Research Therapeutics (START) Midwest has participated in 18 clinical trials with 10 currently active.

Therapeutic areas: Locally Advanced or Metastatic Solid Tumors, Metastatic Cancer, Solid Tumor.

Sponsors: Chugai Pharmaceutical, Symphogen A/S, Eli Lilly and Company.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Grand Rapids

Browse all research sites in Michigan · View every site in Grand Rapids

• Helen DeVos Children's Hospital CF Care Center
• Helen DeVos Childrens Hospital /ID# 79397
• Spectrum Health Hospitals Fred and Lena Meijer Heart Center
• Spectrum Health and DeVos Children's Hospital
• Trinity Health Grand Rapids Hospital
• Spectrum Health Hospital
• Corewell Health Medical Group and Spectrum Health Hospitals
• Corewell Health, for and on behalf of Spectrum Health Hospital and Corewell Health Medical Group
• Mercy Health Saint Mary's Hospital
• Helen DeVos Children's Hospital Pediatric Ophthalmology
• Blodgett Hospital
• Spectrum Health Helen DeVos Children's Hospital Grand Rapids

Sponsor Feasibility Report

Trust Score: 21/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for South Texas Accelerated Research Therapeutics (START) Midwest?

South Texas Accelerated Research Therapeutics (START) Midwest has a Crixeo Trust Score of 21/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has South Texas Accelerated Research Therapeutics (START) Midwest conducted?

South Texas Accelerated Research Therapeutics (START) Midwest has 18 clinical trials on record, with 10 currently active. Their work covers Locally Advanced or Metastatic Solid Tumors, Metastatic Cancer, Solid Tumor.

Is South Texas Accelerated Research Therapeutics (START) Midwest accredited by Crixeo Clinical Trials?

South Texas Accelerated Research Therapeutics (START) Midwest has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about South Texas Accelerated Research Therapeutics (START) Midwest?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.